Lonza has launched its AI-enabled route scouting service offering for small molecules, which combines AI-enabled computer-aided synthesis planning technology from Elsevier operation Reaxys with its own process R&D expertise and supply chain databases. This aims to streamline synthetic route identification.

CDMO EuroAPI has initiated what it calls “a pivotal collaboration” with SpiroChem, a Basel-based CRO that is specialised in chemical process R&D, or route scouting. They will seek to offer consolidated CRO-CDMO services, “ensuring that industrialisation constraints for small molecules are integrated from the initial step of drug design, thereby speeding up the process”.